Gilead Sciences 8-K: Officer & Director Changes
Ticker: GILD · Form: 8-K · Filed: Aug 14, 2025 · CIK: 882095
| Field | Detail |
|---|---|
| Company | Gilead Sciences, INC. (GILD) |
| Form Type | 8-K |
| Filed Date | Aug 14, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes
Related Tickers: GILD
TL;DR
Gilead 8-K filed: board/exec changes reported.
AI Summary
Gilead Sciences, Inc. filed an 8-K on August 14, 2025, reporting events as of August 10, 2025. The filing covers the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding the individuals involved, their roles, and the nature of the compensatory arrangements are not provided in this excerpt.
Why It Matters
Changes in a company's board of directors or executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: low — This filing is procedural, reporting standard corporate governance events without immediate financial implications.
Key Players & Entities
- GILEAD SCIENCES, INC. (company) — Registrant
- August 10, 2025 (date) — Date of earliest event reported
- August 14, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of Incorporation
- 333 Lakeside Drive, Foster City, California 94404 (address) — Principal executive offices
FAQ
What specific officer or director positions were affected by the events reported on August 10, 2025?
The filing indicates changes related to 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers,' but the specific names and positions are not detailed in this excerpt.
Were there any new directors elected to the Gilead Sciences board?
Yes, the filing explicitly lists 'Election of Directors' as an item covered, indicating new directors may have been appointed.
What type of compensatory arrangements were made for certain officers?
The filing mentions 'Compensatory Arrangements of Certain Officers' but does not provide specific details about the nature or value of these arrangements in this excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on August 10, 2025.
What is the principal business address of Gilead Sciences, Inc.?
The principal executive offices are located at 333 Lakeside Drive, Foster City, California 94404.
Filing Stats: 540 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-08-14 16:08:22
Key Financial Figures
- $0.001 — ch registered Common Stock, par value, $0.001 per share GILD The Nasdaq Global Select
Filing Documents
- gild-20250810.htm (8-K) — 23KB
- 0000882095-25-000035.txt ( ) — 135KB
- gild-20250810.xsd (EX-101.SCH) — 2KB
- gild-20250810_lab.xml (EX-101.LAB) — 21KB
- gild-20250810_pre.xml (EX-101.PRE) — 12KB
- gild-20250810_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GILEAD SCIENCES, INC. (Registrant) /s/ DEBORAH H. TELMAN Deborah H. Telman EVP, Corporate Affairs, General Counsel and Corporate Secretary Date: August 14, 2025